Esophageal Cancer
📧 Sign up to get email alerts when something new happens for Esophageal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-06-14Clinical Trial Update: S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus [Phase 2]
Phase 2 trial S0101 evaluating a gemcitabine and irinotecan combination for metastatic or recurrent esophageal and gastric cancer has comple…
-
CLINICAL_TRIALS trial_result · 2012-06-12Clinical Trial Update: Combination Chemotherapy and Interferon Alfa Followed by Surgery and/or Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer [Phase 2]
Clinical trial update indicates termination of a Phase 2 study combining chemotherapy and interferon alfa followed by surgery and/or radiati…
-
CLINICAL_TRIALS trial_result · 2012-06-11Clinical Trial Update: Cetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating a combination of cetuximab, docetaxel, cisplatin, and radiation therapy for locally advanced, surgical…
-
CLINICAL_TRIALS trial_result · 2012-06-05Clinical Trial Update: Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer [Phase 2]
A Phase 2 trial evaluating neoadjuvant therapy with docetaxel and cisplatin plus chemoradiotherapy followed by surgery for locally advanced,…
-
CLINICAL_TRIALS trial_result · 2012-06-05Clinical Trial Update: Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery [Phase 2]
Phase 2 trial evaluating docetaxel, cisplatin, and radiation therapy for locally advanced, unresectable esophageal cancer; study has complet…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-05-24Clinical Trial Update: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the Esophagus [Phase 1, Phase 2]
This document provides an update on a Phase 1/2 clinical trial evaluating combination chemotherapy plus radiation therapy for advanced or me…
-
CLINICAL_TRIALS trial_result · 2012-05-18Clinical Trial Update: Irinotecan, Cisplatin, and Radiation Therapy With or Without Celecoxib in Treating Patients With Stage II, Stage III, or Stage IV Esophageal Cancer [Phase 2]
Phase 2 trial evaluating irinotecan, cisplatin, and radiation therapy with or without celecoxib for Stage II–IV esophageal cancer; the study…
-
CLINICAL_TRIALS trial_result · 2012-05-16Clinical Trial Update: DX-8951f in Treating Patients With Metastatic Stomach Cancer [Phase 2]
Phase 2 clinical trial update on DX-8951f for metastatic gastric cancer and esophageal cancer; the study has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-01Clinical Trial Update: S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial evaluating cetuximab in metastatic esophageal cancer or gastroesophageal junction cancer has completed with results posted in …
-
CLINICAL_TRIALS trial_result · 2012-04-06Clinical Trial Update: Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer [Phase 1]
Phase 1 trial of an HLA-A*2402 restricted peptide vaccine for advanced esophageal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-04-03Clinical Trial Update: S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction [Phase 2]
A Phase 2 SWOG trial evaluating a multimodal regimen of oxaliplatin, 5-fluorouracil, radiation therapy, and surgery for stage II-III esophag…
-
CLINICAL_TRIALS trial_result · 2012-03-26Clinical Trial Update: Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal Cancer
This completed clinical trial investigated venous thromboembolism and haemostatic disturbances in patients with upper gastrointestinal cance…
-
CLINICAL_TRIALS trial_result · 2012-03-23Clinical Trial Update: Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas [Phase 1]
A Phase 1 trial of a combination chemotherapy regimen for patients with recurrent, refractory, or metastatic solid tumors and lymphomas has …
-
CLINICAL_TRIALS trial_result · 2012-03-16Clinical Trial Update: Gefitinib in Treating Patients With Recurrent or Metastatic Esophageal or Gastroesophageal Junction Cancer [Phase 2]
A Phase 2 clinical trial evaluating Gefitinib for recurrent or metastatic esophageal or gastroesophageal junction cancer has completed, with…
-
CLINICAL_TRIALS trial_result · 2012-03-06Clinical Trial Update: S-1 Plus Nedaplatin With Concurrent Radiotherapy for Advanced Esophageal Cancer [Phase 1]
Phase 1 trial evaluating S-1 plus nedaplatin with concurrent radiotherapy for advanced esophageal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-03-06Clinical Trial Update: S-1 and Radiotherapy in Elderly Patients With Esophageal Cancer [Phase 1]
Phase 1 trial update evaluating S-1 with radiotherapy in elderly patients with esophageal cancer. The study has completed.
-
CLINICAL_TRIALS trial_result · 2012-03-02Clinical Trial Update: Study of PEP02, Irinotecan or Docetaxel in Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 2]
A Phase 2 study evaluating PEP02, irinotecan, or docetaxel in gastric or gastroesophageal junction adenocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-02-28Clinical Trial Update: TaxXel: Taxotere and Xeloda in Esophageal Cancer [Phase 1, Phase 2]
An early-phase study (Phase 1/2) evaluating the combination of Taxotere (docetaxel) and Xeloda (capecitabine) in esophageal cancer and gastr…
-
CLINICAL_TRIALS trial_result · 2012-02-23Clinical Trial Update: Pilot Study of 18F-FLT PET [NA]
The pilot study of the 18F-FLT PET tracer was terminated; the study involved patients with brain metastases, head and neck cancer, lung canc…
-
CLINICAL_TRIALS trial_result · 2012-02-07Clinical Trial Update: UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer
Update on the UMCC 003 trial investigating cancer-related protein biomarkers in blood and tumor tissue across several cancers, with the stud…
-
CLINICAL_TRIALS trial_result · 2012-02-03Clinical Trial Update: Complete Clinical Responders to Definite Chemoradiation in Esophageal Cancer : a Survival Analysis
This study analyzes survival among esophageal cancer patients who achieved complete clinical response after definitive chemoradiation in a c…
-
CLINICAL_TRIALS trial_result · 2012-01-13Clinical Trial Update: Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric Carcinomas [Phase 2]
Phase 2 study evaluating cisplatin and irinotecan chemotherapy followed by ZD 1839 (Iressa) in patients with esophageal or gastric carcinoma…
-
CLINICAL_TRIALS trial_result · 2012-01-02Clinical Trial Update: Predictive Proteomic Factors of the Response to Concomitant Radiochemotherapy in Esophageal Cancer [Phase 4]
Phase 4 clinical trial evaluating predictive proteomic factors of response to concomitant radiochemotherapy in esophageal cancer has complet…
-
CLINICAL_TRIALS trial_result · 2011-12-23Clinical Trial Update: Photodynamic Therapy in Treating Patients With Early Esophageal Cancer [Phase 2]
The document updates a Phase 2 clinical trial evaluating photodynamic therapy for early esophageal cancer. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2011-12-06Clinical Trial Update: S-1, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIA, Stage III, or Stage IVA Esophageal Cancer That Can Be Removed by Surgery [Phase 2]
A Phase 2 clinical trial update from Yonsei University evaluating S-1, cisplatin, and radiation therapy for operable esophageal cancer (stag…